The number of deaths has been several in each quarter since around 2015, showing an increasing trend until around the third quarter of 2018.
← all excerpts
Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database.
1
—
—